Showing Form 4 filings for ABEO
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Abeona Therapeutics Inc.
Price
$5.16
Shares
19,608
Ownership
1,286,500
Value/Share
Seshadri Vishwas
CEO
Industry
9,191
482,888
Vazzano Joseph Walter
CFO
6,727
421,226
O'Malley Brendan M.
SVP, GC
4,902
285,721
Vasanthavada Madhav
Chief Commercial Officer